Resource Center

More to Explore - Information About Blood Cancers for Patients, Families and Healthcare Professionals

The Word:


April 3, 2014 - Mantle Cell Lymphoma - Update on Treatment

Your order contains  item(s)  View Order
Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

April 3, 2014
Time: 1:00 p.m. - 2:00 p.m. ET
Location: Telephone/Web
View: Program Slides
Read: Transcript
Listen: Presentation | Q&A Session
Access: Virtual Lecture

Topics Covered

  • Diagnosis of mantle cell lymphoma (MCL)
  • Current and emerging therapies for individuals living with MCL
  • Symptom and side effects management of MCL
  • The role of clinical trials in the continuing improvement of MCL treatment
  • The importance of open communication between patients and their healthcare teams


Brad S. Kahl, MD
Associate Professor of Medicine
Director of Lymphoma Service
University of Wisconsin
Carbone Cancer Center
Madison, WI

Questions Asked by the Mantle Cell Lymphoma Community

  • I am newly diagnosed with mantle cell lymphoma found in my breast.  Is this common and can I start treatment with less toxic medications?
  • With my current medications putting me into remission, at what point do you think I should maybe start a program of ibrutinib (ImbruvicaTM)?
  • What is your opinion on the appropriateness of yearly PET/CT scans for mantle cell lymphoma? 
  • Since my MCL has been diagnosed as slow growing and I do not have any symptoms, is there anything I can do with diet or exercise that can keep the MCL from progressing?
  • How can I find out about clinical trials if my physician has just enough time with me to discuss my current treatment?
  • Are you giving patients Rituxan® maintenance after a stem cell transplant?
  • I am not able to tolerate maintenance Rituxan. Will this be an issue if I relapse?
  • Does ibrutinib (Imbruvica) kill the mantle cells, or just block them from spreading?
  • Is there any data available on using T-cell therapy with MCL when drug therapies have failed?
  • How expensive is ibrutinib (Imbruvica)?
  • I have mantle cell with blastoid variant.  I have undergone a bone marrow transplant.  Will this cure me or can the lymphoma still relapse?

Sponsors and Supporters

This activity was made possible by support from Celgene Corporation, Millennium: The Takeda Oncology Company, and Pharmacyclics, Inc. and Janssen Biotech, Inc.

last updated on Friday, April 17, 2015